Unique ID issued by UMIN | UMIN000044261 |
---|---|
Receipt number | R000050555 |
Scientific Title | Consideration of antibody production of a COMIRNATY intramuscular injection |
Date of disclosure of the study information | 2021/06/07 |
Last modified on | 2022/02/05 11:31:00 |
Consideration of antibody production of a COMIRNATY intramuscular injection
COMIRNATY
Consideration of antibody production of a COMIRNATY intramuscular injection
COMIRNATY
Japan |
COVID-19
Infectious disease |
Others
NO
It's the purpose of this research to make the antibody positive rate by the new-style coronavirus vaccine inoculation, the related gene of antibody production and the gene related to an antibody value change clear. I can think these inspection results will be necessary for future's new-style coronavirus measure and, are some help.
Efficacy
Others
Pragmatic
Not applicable
The antibody positive rate which is 3 months after COMIRNATY intramuscular injection
Observational
20 | years-old | <= |
Not applicable |
Male and Female
1) the staff who took inoculation of a COMIRNATY intramuscular injection in Kamagaya general hospital (I don't ask about the number of times.)
2) the way where the age of the time of the agreement merit is more than 20 years old (I don't ask about the gender.)
3) the back and the way where documentary consent by free will of the patient person himself was got where I had the enough explanation in case of participation of this research
The person who judged that a study person in charge was unsuitable as a subject of research person
551
1st name | Takeshi |
Middle name | |
Last name | Mochizuki |
Kamagaya General Hospital
Plastic surgery
273-0121
929-6 Hatsutomi, Kamagaya-City Chiba
047-498-8266
chiken@kamagaya-hp.jp
1st name | Takeshi |
Middle name | |
Last name | Mochizuki |
Kamagaya General Hospital
Plastic surgery
273-0121
929-6 Hatsutomi, Kamagaya-City Chiba
047-498-8266
chiken@kamagaya-hp.jp
Kamagaya General Hospital
Kamagaya General Hospital
Self funding
The TOKUSHUKAI GROUP ETHICS COMMITTEE
Emina Building 3F,1-8-7 Koji-machi,Chiyoda-ku,Tokyo
03-3263-4801
mirai-ec4@mirai-iryo.com
NO
2021 | Year | 06 | Month | 07 | Day |
Unpublished
370
Completed
2021 | Year | 06 | Month | 30 | Day |
2021 | Year | 06 | Month | 04 | Day |
2021 | Year | 06 | Month | 04 | Day |
2021 | Year | 12 | Month | 28 | Day |
2021 | Year | 12 | Month | 28 | Day |
2021 | Year | 12 | Month | 28 | Day |
2021 | Year | 12 | Month | 28 | Day |
After agreement acquisition of a study, I test an antibody as of 3 or 6 or 9 or 12 months and consider a yes or no of an antibody and the related factor after inoculation of the 1st time of COMIRNATY intramuscular injection.
2021 | Year | 05 | Month | 19 | Day |
2022 | Year | 02 | Month | 05 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050555
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |